stonks4u
Sign up free
CZMWY logo

CZMWY Carl Zeiss Meditec AG

Other OTC · Medical - Instruments & Supplies · Healthcare

$37.17
+2.13 (+6.09%)

Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeuti…

Market Cap: $3.25Bwww.zeiss.com/meditec-ag/de/home.html

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
120
Aug 11Aug 11

Quote

Day Range
$36.65 – $37.29
52-Week Range
$26.65 – $55.94
Volume
$3.6K
Market Cap
$3.25B
50-Day Avg
$32.40
200-Day Avg
$36.26
Prev Close
$35.04
Open
$36.65

Valuation & Ratios

P/E Ratio
27.95
EPS
$1.61
P/B Ratio
1.50
P/S Ratio
1.67
Debt/Equity
0.05
Current Ratio
2.77
Dividend Yield
+1.6%
Gross Margin
+52.8%

Returns & Efficiency

Return on Equity
+5.7%
Return on Assets
+3.5%
FCF Yield
+5.1%
EV/EBITDA
11.03

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.23B$141.21M$1.52
2024$2.07B$178.73M$2.01
2023$2.09B$290.40M$3.25
2022$1.90B$293.91M$3.29
2021$1.65B$236.28M$2.64

Social Signal Score

70
5d
70
1 mentions
—
30d
70
1 mentions
—
60d
70
1 mentions
—
90d
70
1 mentions
—
news: 1

Earnings

Thu, Dec 10(in 4 months)

Consensus estimate $1.38 per share

1of 4 quarters beat consensus

Typical surprise -71.9% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, May 13$0.56 vs $0.56beat
  • Tue, Feb 10$-0.07 vs $1.22miss
  • Tue, May 13$0.57 vs $1.40miss
  • Wed, Feb 12$0.19 vs $1.21miss

Estimates and results for CZMWY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from CZMWY's reported EPS growth of -12.9% a year over 4 years.

EPS in 5 years
$0.81
Implied price
$22.64
Return from $37.17
-9.4% a year

To earn 15.0% a year on these assumptions you'd need to buy at $11.26 — -69.7% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E2024283236
-22.9%-25.1%-22.3%-19.8%-17.7%-15.7%
-17.9%-20.2%-17.2%-14.6%-12.3%-10.2%
-12.9%-15.3%-12.2%-9.4%-7.0%-4.8%
-7.9%-10.5%-7.1%-4.2%-1.6%0.7%
-2.9%-5.6%-2.1%1.0%3.7%6.2%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsseekingalpha.com·4d ago·Positive

    Carl Zeiss Meditec AG (CZMWY) Q3 2026 Earnings Call Transcript Carl Zeiss Meditec AG (CZMWY) Q3 2026 Earnings Call Transcript

    View source ↗